$1043.10−1.02%Close 16 Nov 2026 · Market value $102.7B
In its results release of 28 Oct 2026 (Q3 FY2026), Equinix gave 5 forecasts in figures, among them revenue of $2.68B to $2.72B for Q4 FY2026. Over the last two years, results landed above the company's own last range 6 of 22 times, within it 14 and below it 2.
Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.
Latest guidance given with Q3 FY2026 results, 28 Oct 2026
| Measure | Period | Guidance | As stated |
|---|
| Revenue | Q4 FY2026 | $2.68B to $2.72B | For the fourth quarter of 2026, the company expects revenues to range between $2.684 and $2.724 billion, an increase of 11 - 13% over the previous year on an as-reported basis, or 12 - 13% on a normalized and constant currency basis |
|---|
| EBITDA · Adjusted | Q4 FY2026 | $1.33B to $1.37B | Adjusted EBITDA is expected to range between $1.328 and $1.368 billion, reflecting an adjusted EBITDA margin of 49 - 50%. |
|---|
| Revenue | FY2026 | $10.32B to $10.37B | For the full year of 2026, total revenues are expected to range between $10.325 and $10.365 billion, an increase of approximately 12% over the previous year on both an as-reported and a normalized and constant currency basis |
|---|
| EBITDA · Adjusted | FY2026 | $5.29B to $5.33B | Adjusted EBITDA is expected to range between $5.290 and $5.330 billion, reflecting an adjusted EBITDA margin of approximately 51%, an approximate 200 basis points expansion over the previous year |
|---|
| Capital expenditures | FY2026 | $5.00B to $6.00B | Total capital expenditures are expected to range between $5 and $6 billion. |
|---|
Source: the company's earnings release.
Guidance against results above 6 · within 14 · below 2
The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.
| Measure | Period | Last guidance | Revisions | Delivered | Result |
|---|
| Revenue | FY2026 | $10.32B to $10.37B | Raised twice | — | To come |
|---|
| Revenue growth | FY2026 | +10% to +13% | Given once | — | To come |
|---|
| EBITDA · Adjusted | FY2026 | $5.29B to $5.33B | Raised 3 times | — | To come |
|---|
| Capital expenditures | FY2026 | $5.00B to $6.00B | Raised twice | — | To come |
|---|
| AFFO growth | FY2026 | +9% to +12% | Unchanged | — | To come |
|---|
| Revenue | Q4 FY2026 | $2.68B to $2.72B | Given once | — | To come |
|---|
| EBITDA · Adjusted | Q4 FY2026 | $1.33B to $1.37B | Given once | — | To come |
|---|
| Revenue | Q3 FY2026 | $2.52B to $2.58B | Given once | $2.57B | Within the range |
|---|
| EBITDA · Adjusted | Q3 FY2026 | $1.27B to $1.31B | Given once | $1.32B | Above the range |
|---|
| Revenue | Q2 FY2026 | $2.57B to $2.61B | Given once | $2.63B | Above the range |
|---|
| EBITDA · Adjusted | Q2 FY2026 | $1.35B to $1.39B | Given once | $1.40B | Above the range |
|---|
| Revenue | Q1 FY2026 | $2.50B to $2.54B | Given once | $2.44B | Below the range |
|---|
| EBITDA · Adjusted | Q1 FY2026 | $1.28B to $1.32B | Given once | $1.25B | Below the range |
|---|
| Revenue | FY2025 | $9.21B to $9.33B | Raised once, lowered once | $9.22B | Within the range |
|---|
| EBITDA · Adjusted | FY2025 | $4.53B to $4.61B | Raised twice | $4.53B | Within the range |
|---|
| Capital expenditures | FY2025 | $3.79B to $4.29B | Raised once | $4.31B | Above the range |
|---|
| Revenue | Q4 FY2025 | $2.41B to $2.53B | Given once | $2.42B | Within the range |
|---|
| EBITDA · Adjusted | Q4 FY2025 | $1.19B to $1.27B | Given once | $1.19B | Within the range |
|---|
| Revenue | Q3 FY2025 | $2.31B to $2.33B | Unchanged | $2.32B | Within the range |
|---|
| EBITDA · Adjusted | Q3 FY2025 | $1.14B to $1.16B | Unchanged | $1.15B | Within the range |
|---|
| Revenue | Q2 FY2025 | $2.24B to $2.26B | Given once | $2.26B | Within the range |
|---|
| EBITDA · Adjusted | Q2 FY2025 | $1.09B to $1.11B | Given once | $1.13B | Above the range |
|---|
| Revenue | Q1 FY2025 | $2.19B to $2.23B | Given once | $2.23B | Within the range |
|---|
| EBITDA · Adjusted | Q1 FY2025 | $1.01B to $1.05B | Given once | $1.07B | Above the range |
|---|
EQIX in the terminal
Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.